查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1701862

2025 年至 2033 年灰指甲治療市場報告（按疾病類型、治療類型、藥物類別、配銷通路和地區）

Onychomycosis Treatment Market Report by Disease Type, Treatment Type, Drug Class, Distribution Channel, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 143 Pages | 商品交期: 2-3個工作天內

價格

2024年全球灰指甲治療市場規模達36億美元。展望未來， IMARC Group預計到2033年市場規模將達到54億美元，2025-2033年期間的成長率（CAGR）為4.5%。由於擴大接觸公共游泳池以及使用緊身、受污染或髒污的衣服、鞋子、襪子等，這種真菌感染在成年人和千禧一代中的患病率不斷上升，這主要推動了市場的發展。

甲癬是一種發生在手指甲和腳趾甲的真菌感染，可導致不適、慢性疼痛和毀容。甲癬的類型包括近端甲下型、白色表層型和遠端甲下型。它是足癬患者常見的指甲感染，由多種生物引起，例如皮癬菌、酵母菌和非皮癬菌黴菌。甲癬的特徵症狀包括指甲形狀變形、惡臭、顏色由白色到黃褐色變化、指甲質地脆弱、粗糙和易碎。通常透過鉀、氧和氫 (KOH) 檢查、指甲剪和指甲活體組織切片的培養和組織病理學檢查來診斷，並透過雷射療法、藥物和光動力療法進行治療。

灰指甲治療市場趨勢：

甲癬、人類免疫缺陷病毒 (HIV)、糖尿病和周邊動脈疾病 (PAD) 等慢性疾病的盛行率不斷上升，是推動市場成長的關鍵因素之一。此外，老年人口的增加也為市場成長提供了動力，老年人更容易罹患循環系統疾病和免疫系統減弱。由於千禧世代和成年人更多地接觸公共游泳池以及穿著緊身、受污染或髒污的衣服、鞋子和襪子，灰指甲病在千禧世代和成年人中也非常普遍。此外，可口服的水溶性抗真菌治療溶液的開發也為市場成長提供了推動力。它們有助於預防繼發性細菌感染並防止真菌生長。其他因素，包括廣泛使用外用指甲油和藥膏來保持指甲衛生，以及醫療保健基礎設施的顯著改善，預計將推動市場成長。

本報告回答的關鍵問題

  • 2024 年全球灰指甲治療市場規模？ 2025-2033年全球灰指甲治療市場的預期成長率是多少？
  • 推動全球甲癬治療市場發展的關鍵因素有哪些？
  • COVID-19 對全球甲癬治療市場有何影響？
  • 根據疾病類型，全球灰指甲治療市場是如何分佈的？
  • 根據治療類型，全球甲癬治療市場是如何分佈的？
  • 根據配銷通路，全球灰指甲治療市場如何分佈？
  • 全球灰指甲治療市場的主要區域有哪些？
  • 全球甲癬治療市場的主要參與者/公司有哪些？

目錄

第1章：前言

第2章：範圍與方法

  • 研究目標
  • 利害關係人
  • 資料來源
    • 主要來源
    • 次要來源
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章：執行摘要

第4章：簡介

  • 概述
  • 主要行業趨勢

第5章：全球甲癬治療市場

  • 市場概覽
  • 市場表現
  • COVID-19的影響
  • 市場預測

第6章：市場區隔：依疾病類型

  • 遠端甲下甲癬
  • 近端甲下甲癬
  • 白色表淺性甲真菌病
  • 念珠菌性甲癬
  • 其他

第7章：市場區隔：依治療類型

  • 雷射治療
  • 光動力療法
  • 藥物治療

第8章：市場區隔：依藥品類別

  • 烯丙胺
  • 唑類
  • 灰黃黴素
  • 其他

第9章：市場區隔：按配銷通路

  • 醫院和診所
  • 網路商店
  • 零售藥局
  • 其他

第10章：市場細分：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場區隔：依國家

第 11 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 12 章：價值鏈分析

第 13 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 14 章：價格分析

第 15 章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Bausch Health Companies Inc.
    • Cipla Limited
    • Dr. Reddy's Laboratories
    • Galderma SA
    • GlaxoSmithKline PLC
    • Kaken Pharmaceutical Co. Ltd
    • Lumenis Ltd
    • Moberg Pharma AB
    • Novartis AG
    • Pfizer Inc.
    • The OTC Lab BV
Product Code: SR112025A4877

The global onychomycosis treatment market size reached USD 3.6 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 5.4 Billion by 2033, exhibiting a growth rate (CAGR) of 4.5% during 2025-2033. The rising prevalence of this fungal infection among adults and millennials due to the increased exposure to public swimming pools and the use of tight, contaminated, or soiled clothes, shoes, socks, etc., is primarily driving the market.

Onychomycosis is a fungal infection that occurs in the fingernails and toenails that can lead to discomfort, chronic pain and disfigurement. Proximal subungual, white superficial and distal subungual are some of the types of onychomycosis. It is a common nail infection in patients with athlete's foot and is caused by various organisms, such as dermatophytes, yeasts and non-dermatophyte molds. Onychomycosis is characterized by symptoms, including distortion in the shape of nails, foul smell, whitish to yellow-brown discoloration and brittle, ragged and crumbly texture of the nails. It is usually diagnosed through potassium, oxygen and hydrogen (KOH) examination, culture and histopathological examinations of nail clippings and nail biopsies and is treated through laser therapy, drugs and photodynamic therapies.

Onychomycosis Treatment Market Trends:

The increasing prevalence of chronic medical ailments, such as onychomycosis, human immunodeficiency virus (HIV), diabetes and peripheral artery disease (PAD), is one of the key factors driving the growth of the market. Moreover, the rising geriatric population, which is highly prone to circulatory disorders and weakened immune system, is providing a thrust to the market growth. Onychomycosis is also highly prevalent among millennials and adults due to the increased exposure to public swimming pools and utilization of tight, contaminated or soiled clothes, shoes and socks. Additionally, the development of water-soluble antifungal treatment solutions that can be administered orally is providing a thrust to the market growth. They aid in preventing secondary bacterial infections and prevent the growth of fungus. Other factors, including the widespread utilization of topical nail lacquers and ointments to maintain nail hygiene, along with the significant improvements in the healthcare infrastructure, are anticipated to drive the market toward growth.

Key Market Segmentation:

Breakup by Disease Type:

  • Distal Subungual Onychomycosis
  • Proximal Subungual Onychomycosis
  • White Superficial Onychomycosis
  • Candidal Onychomycosis
  • Others

Breakup by Treatment Type:

  • Laser Therapy
  • Photodynamic Therapy
  • Drug Treatment

Breakup by Drug Class:

  • Allylamine
  • Azole
  • Griseofulvin
  • Others

Breakup by Distribution Channel:

  • Hospitals and Clinics
  • Online Stores
  • Retail Pharmacies
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Bausch Health Companies Inc., Cipla Limited, Dr. Reddy's Laboratories, Galderma SA, GlaxoSmithKline PLC, Kaken Pharmaceutical Co. Ltd, Lumenis Ltd, Moberg Pharma AB, Novartis AG, Pfizer Inc. and The OTC Lab B.V.

Key Questions Answered in This Report

  • 1.What was the size of the global onychomycosis treatment market in 2024?
  • 2.What is the expected growth rate of the global onychomycosis treatment market during 2025-2033?
  • 3.What are the key factors driving the global onychomycosis treatment market?
  • 4.What has been the impact of COVID-19 on the global onychomycosis treatment market?
  • 5.What is the breakup of the global onychomycosis treatment market based on the disease type?
  • 6.What is the breakup of the global onychomycosis treatment market based on the treatment type?
  • 7.What is the breakup of the global onychomycosis treatment market based on the distribution channel?
  • 8.What are the key regions in the global onychomycosis treatment market?
  • 9.Who are the key players/companies in the global onychomycosis treatment market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Onychomycosis Treatment Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Disease Type

  • 6.1 Distal Subungual Onychomycosis
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Proximal Subungual Onychomycosis
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 White Superficial Onychomycosis
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Candidal Onychomycosis
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Others
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Treatment Type

  • 7.1 Laser Therapy
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Photodynamic Therapy
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Drug Treatment
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Drug Class

  • 8.1 Allylamine
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Azole
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Griseofulvin
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Distribution Channel

  • 9.1 Hospitals and Clinics
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Online Stores
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Retail Pharmacies
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Bausch Health Companies Inc.
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Cipla Limited
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 Dr. Reddy's Laboratories
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 Galderma SA
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 GlaxoSmithKline PLC
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 Kaken Pharmaceutical Co. Ltd
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
    • 15.3.7 Lumenis Ltd
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 SWOT Analysis
    • 15.3.8 Moberg Pharma AB
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
    • 15.3.9 Novartis AG
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Pfizer Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11 The OTC Lab B.V.
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio

List of Figures

  • Figure 1: Global: Onychomycosis Treatment Market: Major Drivers and Challenges
  • Figure 2: Global: Onychomycosis Treatment Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Onychomycosis Treatment Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Onychomycosis Treatment Market: Breakup by Disease Type (in %), 2024
  • Figure 5: Global: Onychomycosis Treatment Market: Breakup by Treatment Type (in %), 2024
  • Figure 6: Global: Onychomycosis Treatment Market: Breakup by Drug Class (in %), 2024
  • Figure 7: Global: Onychomycosis Treatment Market: Breakup by Distribution Channel (in %), 2024
  • Figure 8: Global: Onychomycosis Treatment Market: Breakup by Region (in %), 2024
  • Figure 9: Global: Onychomycosis Treatment (Distal Subungual Onychomycosis) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Onychomycosis Treatment (Distal Subungual Onychomycosis) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Onychomycosis Treatment (Proximal Subungual Onychomycosis) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Onychomycosis Treatment (Proximal Subungual Onychomycosis) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Onychomycosis Treatment (White Superficial Onychomycosis) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Onychomycosis Treatment (White Superficial Onychomycosis) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Onychomycosis Treatment (Candidal Onychomycosis) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Onychomycosis Treatment (Candidal Onychomycosis) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Onychomycosis Treatment (Other Disease Types) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Onychomycosis Treatment (Other Disease Types) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: Global: Onychomycosis Treatment (Laser Therapy) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: Global: Onychomycosis Treatment (Laser Therapy) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: Global: Onychomycosis Treatment (Photodynamic Therapy) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: Global: Onychomycosis Treatment (Photodynamic Therapy) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: Global: Onychomycosis Treatment (Drug Treatment) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: Global: Onychomycosis Treatment (Drug Treatment) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: Global: Onychomycosis Treatment (Allylamine) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: Global: Onychomycosis Treatment (Allylamine) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: Global: Onychomycosis Treatment (Azole) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: Global: Onychomycosis Treatment (Azole) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: Global: Onychomycosis Treatment (Griseofulvin) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: Global: Onychomycosis Treatment (Griseofulvin) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: Global: Onychomycosis Treatment (Other Drug Classes) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: Global: Onychomycosis Treatment (Other Drug Classes) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: Global: Onychomycosis Treatment (Hospitals and Clinics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: Global: Onychomycosis Treatment (Hospitals and Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: Global: Onychomycosis Treatment (Online Stores) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: Global: Onychomycosis Treatment (Online Stores) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: Global: Onychomycosis Treatment (Retail Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: Global: Onychomycosis Treatment (Retail Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: Global: Onychomycosis Treatment (Other Distribution Channels) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: Global: Onychomycosis Treatment (Other Distribution Channels) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: North America: Onychomycosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: North America: Onychomycosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: United States: Onychomycosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: United States: Onychomycosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: Canada: Onychomycosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: Canada: Onychomycosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: Asia-Pacific: Onychomycosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: Asia-Pacific: Onychomycosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: China: Onychomycosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: China: Onychomycosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: Japan: Onychomycosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: Japan: Onychomycosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: India: Onychomycosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: India: Onychomycosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: South Korea: Onychomycosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: South Korea: Onychomycosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: Australia: Onychomycosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: Australia: Onychomycosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: Indonesia: Onychomycosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: Indonesia: Onychomycosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: Others: Onychomycosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: Others: Onychomycosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: Europe: Onychomycosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: Europe: Onychomycosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 65: Germany: Onychomycosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 66: Germany: Onychomycosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 67: France: Onychomycosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 68: France: Onychomycosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 69: United Kingdom: Onychomycosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 70: United Kingdom: Onychomycosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 71: Italy: Onychomycosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 72: Italy: Onychomycosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 73: Spain: Onychomycosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 74: Spain: Onychomycosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 75: Russia: Onychomycosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 76: Russia: Onychomycosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 77: Others: Onychomycosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 78: Others: Onychomycosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 79: Latin America: Onychomycosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 80: Latin America: Onychomycosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 81: Brazil: Onychomycosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 82: Brazil: Onychomycosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 83: Mexico: Onychomycosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 84: Mexico: Onychomycosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 85: Others: Onychomycosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 86: Others: Onychomycosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 87: Middle East and Africa: Onychomycosis Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 88: Middle East and Africa: Onychomycosis Treatment Market: Breakup by Country (in %), 2024
  • Figure 89: Middle East and Africa: Onychomycosis Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 90: Global: Onychomycosis Treatment Industry: SWOT Analysis
  • Figure 91: Global: Onychomycosis Treatment Industry: Value Chain Analysis
  • Figure 92: Global: Onychomycosis Treatment Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Onychomycosis Treatment Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Onychomycosis Treatment Market Forecast: Breakup by Disease Type (in Million USD), 2025-2033
  • Table 3: Global: Onychomycosis Treatment Market Forecast: Breakup by Treatment Type (in Million USD), 2025-2033
  • Table 4: Global: Onychomycosis Treatment Market Forecast: Breakup by Drug Class (in Million USD), 2025-2033
  • Table 5: Global: Onychomycosis Treatment Market Forecast: Breakup by Distribution Channel (in Million USD), 2025-2033
  • Table 6: Global: Onychomycosis Treatment Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 7: Global: Onychomycosis Treatment Market: Competitive Structure
  • Table 8: Global: Onychomycosis Treatment Market: Key Players